Posts tagged Edi Truell

First UK-based clinical trial manufacturer focused on viral vectors announces launch

ViroCell will supply viral vectors and gene modified cells, to academic and corporate clients, for translational cell and gene therapies going into clinical trials.

In the NewsFlorence BuchananApril 29, 2021CDMO, clinical trials, viral vectors, cell and gene therapies, CCR, Complete Clinical Research, gene therapy, cell therapy, vector design, AAV vectors, lentivirus vectors, UK CDMO, ViroCell, Edi Truell

Edi Truell leads financing of gene therapy start-up ViroCell Biologics

Edi Truell is backing a gene and cell therapy start-up and is seeking to lead a £100 million financing as part of his latest venture.

In the NewsFlorence BuchananApril 12, 2021Edi Truell, gene therapy, cell therapy, CDMO, UK CDMO, viral vector, viral vectors, AAV vectors, lentivirus vectors, ViroCell, The Times, Farzin Farzaneh, John W. Hadden II, Truell Conservaton Foundation, Danny Truell, Syncona

In the news

London New York